Insider selling
Traded Nov 21, 2025 · filed 4 days laterNot reported under a pre-arranged trading plan
Steris's Sr. VP and GM, Life Sciences sold $752K of Steris shares. The filing does not indicate a pre-arranged trading plan.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 21, 2025 · Filed Nov 25, 2025
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
option exercise
Code M — exercise or conversion of a derivative security
None found in footnotes
Only flagged when a footnote says so; never inferred
Insider selling
Traded Nov 21, 2025 · filed 4 days laterNot reported under a pre-arranged trading plan
Steris's Sr. VP and GM, Life Sciences sold $752K of Steris shares. The filing does not indicate a pre-arranged trading plan.
Insider filing
Traded Nov 21, 2025 · filed 4 days later
Derivative exercise or conversion — not an open-market buy.
Insider selling
Traded Nov 21, 2025 · filed 4 days laterNot reported under a pre-arranged trading plan
Steris's Sr. VP and GM, Life Sciences sold $560K of Steris shares. The filing does not indicate a pre-arranged trading plan.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
The company's last weighty Form 8-K report up to this date: reported its results, 16 days earlier (Nov 5, 2025). The first one after it: reported its results, 75 days later (Feb 4, 2026).